PainReform (PainReform) Accounts Payable & Accrued Expense : $2.68 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is PainReform Accounts Payable & Accrued Expense?

PainReform's quarterly accounts payable & accrued expense increased from Sep. 2023 ($0.67 Mil) to Dec. 2023 ($1.89 Mil) and increased from Dec. 2023 ($1.89 Mil) to Mar. 2024 ($2.68 Mil).

PainReform's annual accounts payable & accrued expense increased from Dec. 2021 ($0.33 Mil) to Dec. 2022 ($0.57 Mil) and increased from Dec. 2022 ($0.57 Mil) to Dec. 2023 ($1.89 Mil).

PainReform Accounts Payable & Accrued Expense Historical Data

The historical data trend for PainReform's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PainReform Accounts Payable & Accrued Expense Chart

PainReform Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.15

0.87

0.33

0.57

1.89

PainReform Quarterly Data
	Dec18	Jun19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															0.75	0.60	0.67	1.89	2.68

PainReform Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

PainReform (PainReform) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PainReform Ltd (NAS:PRFX) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Yigal Alon Street, Tel Aviv, ISR, 6744316

Website

https://www.painreform.com

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.